Another study reported that plasma VEGF-B elevated in newly diagnosed T2DM and impaired glucose regulation (IGR) patients, compared with healthy controls (Wu et al., 2017[40]). This evidence concerns the gene VEGFB and type 2 diabetes mellitus.